Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.

• Phase: Phase 4

Details

• Lead Sponsor: Innovative Medical
• Treatments: Ketorolac; Ketorolac Tromethamine; Nepafenac

Criteria

Inclusion Criteria:

• · Male or female > 18 years of age scheduled to undergo cataract surgery

• Must be in good general health. Patients with systemic diseases will be enrolled only if there are no ocular manifestations of their disease (ie diabetics with normal retinal exams)

• Ability to provide informed consent and likely to complete all study visits

Exclusion Criteria:

• · Known contraindication to any study medication or any of their components

• Uncontrolled systemic disease

• Required use of ocular medications other than the study medications during the study

• Abnormal pre-operative OCTs if obtainable

• Diabetic patients

• Use of oral NSAIDS

• Patients with ocular disease (macula degeneration, glaucoma, corneal disease) which reduces the potential visual rehabilitation (patients will ocular disease that will no preclude achievement of a 20/20 visual outcome may be included)..